Previous 10 | Next 10 |
2023-04-27 06:08:25 ET Sanofi ( NASDAQ: SNY ) Q1 profit rose beating estimates as blockbuster drug Dupixent performed well again. Business EPS rose +11.3% Y/Y on a reported basis (+11.9% at constant exchange rates, or CER) to €2.16. Q1 sales grew +5.7% Y/Y (+5.5% CER)...
2023-04-26 17:15:43 ET For further details see: Partial clinical hold placed on Alnylam, Regeneron RNAi Alzheimer's candidate
– Single Doses of ALN-APP Demonstrated Dose-Dependent, Rapid and Sustained Reduction of sAPPα and sAPPβ in Cerebrospinal Fluid, with Up to 90% at Highest Dose to Date – – Encouraging Clinical Safety and Tolerability Profile Observed with Single Dosing ...
- Single Doses of ALN-APP Demonstrated Dose-Dependent, Rapid and Sustained Reduction of sAPPα and sAPPβ in Cerebrospinal Fluid, with Up to 90% at Highest Dose to Date - - Encouraging Clinical Safety and Tolerability Profile Observed with Single Dosing to Date - - R...
2023-04-26 13:21:35 ET A group of 23 Democratic senators led by Amy Klobuchar (Minn.) and Peter Welch (Vt.) have introduced legislation that would allow CMS to negotiate the price of drugs five years after approval. In addition, the bill, the Strengthening Medicare and Reducing Taxp...
2023-04-25 13:00:00 ET The biotechnology sector is a highly innovative and dynamic industry that is constantly evolving. Biotech companies develop and produce drugs, therapies, and other products that are designed to improve health outcomes for patients. The sector has a significant impact ...
2023-04-21 13:45:05 ET Summary Shares of CRISPR-Cas9 genomic editor Intellia Therapeutics, Inc. have retreated over 80% since hitting an all-time intraday high of $202.73 in late June 2021. Despite the pullback, very early returns suggest a functional cure for HAE and (possibly) A...
2023-04-20 08:18:28 ET Sensei Biotherapeutics ( NASDAQ: SNSE ) received US FDA approval for its Investigational New Drug ( IND ) application for SNS-101, an antibody for solid tumors. The company will now proceed with a phase 1 trial of SNS-101 as both monotherapy and ...
2023-04-18 23:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
TARRYTOWN, N.Y., April 17, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that P. Roy Vagelos, M.D., will retire from his role as Chair of the Company’s Board of Directors and will not stand for reelection at the Company’s 2023 Annual Me...
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
2024-07-12 11:00:05 ET Trung Huynh from UBS issued a price target of $1,250.00 for REGN on 2024-07-12 10:18:00. The adjusted price target was set to $1,250.00. At the time of the announcement, REGN was trading at $1092.3075. The overall price target consensus is at $902....
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...